Inventor
NIVOROZHKIN ALEX
US29 patents
⚠️ This page may combine multiple inventors who share the name “NIVOROZHKIN ALEX”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CYBIN IRL LTD
9 patentsUS11242318B2Feb 8, 2022
Deuterated tryptamine derivatives and methods of use
CYBIN IRL LTD38 citations96
US11958807B2Apr 16, 2024
Deuterated tryptamine derivatives and methods of use
CYBIN IRL LTD3 citations85
US11834410B2Dec 5, 2023
Deuterated tryptamine derivatives and methods of use
CYBIN IRL LTD5 citations83
US11746088B2Sep 5, 2023
Deuterated tryptamine derivatives and methods of use
CYBIN IRL LTD5 citations83
US11724985B2Aug 15, 2023
Deuterated tryptamine derivatives and methods of use
CYBIN IRL LTD7 citations83
US12291499B2May 6, 2025
Deuterated tryptamine derivatives and methods of use
CYBIN IRL LTD0 citations62
US12240813B2Mar 4, 2025
Deuterated tryptamine derivatives and methods of use
CYBIN IRL LTD0 citations60
US12110272B2Oct 8, 2024
Deuterated tryptamine derivatives and methods of use
CYBIN IRL LTD0 citations60
US12122741B2Oct 22, 2024
Therapeutic phenethylamine compositions and methods of use
CYBIN IRL LTD0 citations52
AMORSA THERAPEUTICS INC
7 patentsUS10252982B2Apr 9, 2019
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
AMORSA THERAPEUTICS INC14 citations93
US9913803B2Mar 13, 2018
Single-layer oral dose of neuro-attenuating ketamine
AMORSA THERAPEUTICS INC12 citations92
US10653629B2May 19, 2020
Single layer oral dose of neuro-attenuating ketamine
AMORSA THERAPEUTICS INC6 citations83
US11613515B2Mar 28, 2023
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
AMORSA THERAPEUTICS INC2 citations72
US11603348B2Mar 14, 2023
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
AMORSA THERAPEUTICS INC1 citations72
US11554100B2Jan 17, 2023
Single-layer oral dose of neuro-attenuating ketamine
AMORSA THERAPEUTICS INC2 citations72
US10981859B2Apr 20, 2021
Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods
AMORSA THERAPEUTICS INC1 citations72
DRINKSAVVY INC
3 patentsUS9285352B2Mar 15, 2016
System and method for detection of a contaminated beverage
DRINKSAVVY INC15 citations91
US10274475B2Apr 30, 2019
System and method for detection of a contaminated beverage
DRINKSAVVY INC2 citations71
US9989509B2Jun 5, 2018
System and method for detection of a contaminated beverage
DRINKSAVVY INC0 citations50
INOTEK PHARMACEUTICALS CORP
3 patentsUS7078423B2Jul 18, 2006
5-Aryltetrazole compounds, compositions thereof, and uses therefor
INOTEK PHARMACEUTICALS CORP6 citations61
US7087631B2Aug 8, 2006
Aryltetrazole compounds, and compositions thereof
INOTEK PHARMACEUTICALS CORP3 citations60
US7135491B2Nov 14, 2006
5-Aryltetrazole compounds and uses thereof
INOTEK PHARMACEUTICALS CORP0 citations50
ONIKIENKO SERGEI B
3 patentsUS9937241B2Apr 10, 2018
Degradation resistant HSP70 formulations and uses thereof
ONIKIENKO SERGEI B0 citations42
US9616100B2Apr 11, 2017
Methods of use of HSP70 for increased performance or treatment of HSP70 related disorders
ONIKIENKO SERGEI B0 citations40
US9217018B2Dec 22, 2015
HSP70 fusion protein conjugates and uses thereof
ONIKIENKO SERGEI B0 citations35